Expression, purification and immunodetection of a recombinant fragment (residues 179-281) of the G protein from rabies virus ERA strain

Protein Expression and Purification

Volumn 59, Issue 2, 2008, Pages 309-313

  Bassi, Ênio J ^a   Vernal, Javier ^a   Zanluca, Camila ^a   Terenzi, Hernán ^a   Zanetti, Carlos R ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Heterologous expression; Rabies virus diagnostic method; Rabies virus G protein

Indexed keywords

EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; IMMUNOGLOBULIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; ESCHERICHIA COLI; GENE VECTOR; GENETICS; HUMAN; IMMUNOCHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MOLECULAR GENETICS; SERODIAGNOSIS;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; ESCHERICHIA COLI; GENETIC VECTORS; GLYCOPROTEINS; HUMANS; IMMUNOCHEMISTRY; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULINS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS;

ESCHERICHIA COLI; RABIES VIRUS;

EID: 42749097507     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.02.014     Document Type: Article

References (34)

1. Warrel M.J., and Warrel D.A. Rabies and other lyssavirus diseases. The Lancet 363 (2004) 959-969
2. Tordo N. Characteristics and molecular biology of the rabies virus. In: Meslin F.-X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), World Health Organization, Geneva 28-51
3. Anilionis A., Wunner W.H., and Curtis P.J. Structure of the glycoprotein gene in rabies virus. Nature 294 (1981) 275-278
4. Coll J.M. The glycoprotein G of rhabdoviruses. Arch. Virol. 140 (1995) 851-987
5. Gaudin Y., Ruigrok R., Tuffereau C., Knossow M., and Flamand A. Rabies glycoprotein is a trimer. Virology 187 (1992) 627-632
6. Rath A., Choudhury S., Batra D., Kapre S.V., Rupprecht C.E., and Gupta S.K. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Virus Res. 113 (2005) 143-152
7. Perrin P., Thibodeau L., and Sureau P. Rabies immunosomes (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies. Vaccine 3 (1985) 325-332
8. Wiktor T., Gyorgy E., Schlumberger D., Sokol F., and Koprowski H. Antigenic properties of rabies virus components. J. Immunol. 110 (1973) 269-276
9. Cox J.H., Dietzschold B., and Schneider L.G. Rabies virus glycoprotein. II Biological and serological characterization. Infect. Immun. 16 (1977) 754-759
10. Macfarlan R.I., Dietzschold B., and Koprowski H. Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain. Mol. Immunol. 23 (1986) 733-741
11. Celis E., Ou D., Dietzschold B., and Koprowski H. Recognition of rabies and rabies-related virus by T cells derived from human vaccine recipients. J. Virol. 62 (1988) 3128-3134
12. Bunschoten H., Gore M., Claassen I.J.T.M., Uytdehaag F.G.C.M., Dietzschold B., Wunner W.H., and Osterhaus A.D.M.E. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J. Gen. Virol. 70 (1989) 291-298
13. Dietzschold B., Gore M., Marchadier D., Niu H.S., Bunschoten H.M., Otvos Jr. L., Wunner H.W., Ertl H.C.J., Osterhaus A.D.M.E., and Koprowski H. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 64 (1990) 3804-3809
14. Van der Heijden R.W.J., Langedijk J.P.M., Groen J., Uytdehaag F.G.C.M., Meloen R.H., and Osterhaus A.D.M.E. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. J. Gen. Virol. 74 (1993) 1539-1545
15. Luo T.R., Minamoto N., Ito H., Goto H., Hiraga S., Ito N., Sugiyama M., and Kinjo T. A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Res. 51 (1997) 35-41
16. Lafay F., Benmansour A., Chebli K., and Flamand A. Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. J. Gen. Virol. 77 (1996) 339-346
17. Ni Y., Tominaga Y., Honda Y., Morimoto K., Sakamoto S., and Kawai A. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719. Microbiol. Immunol. 39 (1995) 693-702
18. Marissen W.E., Kramer R.A., Rice A., Weldon W.C., Niezgoda M., Faber M., Slootstra J.W., Meloen R.H., der Horst M.C., Visser T.J., Jongeneelen M., Thijsse S., Throsby M., Kruif J., Rupprecht C.E., Dietzschold B., Goudsmit J., and Bakker A.B.H. Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J. Virol. 79 (2005) 4672-4678
19. Johnson N., Mansfield K.L., and Fooks A.R. Canine vaccine recipients recognize an immunodominant region of the rabies virus glycoprotein. J. Gen. Virol. 83 (2002) 2663-2669
20. Motoi Y., Sato K., Hatta H., Morimoto K., Inoue S., and Yamada A. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli. Vaccine 23 (2005) 3026-3032
21. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., and Ertl H.C.J. Immune responses to nucleic acid vaccines to rabies virus. Virology 209 (1995) 569-579
22. Thomas J.G., and Baneyx F. Divergent effects of chaperone overexpression and ethanol supplementation on inclusion body formation in recombinant Escherichia coli. Protein Expr. Purif. 11 (1997) 289-296
23. Shägger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
25. Westermeier R., and Naven T. Proteomics in Practice. A Laboratory Manual of Proteome Analysis (2002), Wiley-VCH, Weinheim
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. Favoretto S.R., Carrieri M.L., Tino M.S., Zanetti C.R., and Pereira O.A.C. Simplified fluorescence inhibition microtest for the titration of rabies neutralizing antibodies. Rev. Inst. Med. Trop. Sao Paulo 35 (1993) 171-175
28. Yelverton E., Norton S., Obijeski J.F., and Goeddel D.V. Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli. Science 219 (1983) 614-619
29. Sakamoto S., Ide T., Tokiyoshi S., Nakao J., Hamada F., Yamamoto M., Grosby J.A., Ni Y., and Kawai A. Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells. Vaccine 17 (1999) 205-518
30. Yokomizo A.Y., Jorge S.A.C., Astray R.M., Fernandes I., Ribeiro O.G., Horton D.S.P.Q., Tonso A., Tordo N., and Pereira C.A. Rabies virus glycoprotein expression in Drosophila S2 cells. I. Functional recombinant protein in stable co-transfected cell line. Biotechnol. J. 2 (2007) 102-109
31. Abelseth M.K. An attenuated rabies vaccine for domestic animals produced in tissue culture. Can. Vet. J. 5 (1964) 279-286
32. Nicholson K.G. Cell-culture vaccines for human use: general considerations. In: Meslin F.-X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), World Health Organization, Geneva 271-279
33. Wilbur L.A., and Aubert M.F.A. The NIH test for potency. In: Meslin F.-X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), World Health Organization, Geneva 360-368
34. Barth R., Diderrich G., and Weinmann E. NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine 6 (1988) 369-377